Drugs / Venalfaxine
Venalfaxine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00797966 Background | May 2009 → Jun 2010 | major depressive disorder | Otsuka Pharmaceutical Development & Commercialization, Inc. | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Venalfaxine | “Venalfaxine XR (Effexor XR)” NCT00797966 ↗ |
| Known as | Effexor XR | “Venalfaxine XR (Effexor XR)” NCT00797966 ↗ |
| Known as | Venalfaxine XR | “Venalfaxine XR (Effexor XR)” NCT00797966 ↗ |